These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 37408276)

  • 1. Roles of Aging, Circular RNAs, and RNA Editing in the Pathogenesis of Amyotrophic Lateral Sclerosis: Potential Biomarkers and Therapeutic Targets.
    Hosaka T; Tsuji H; Kwak S
    Cells; 2023 May; 12(10):. PubMed ID: 37408276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
    Hosaka T; Tsuji H; Kwak S
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
    Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
    Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    Kwak S; Kawahara Y
    J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the impact of circular RNA on ALS progression: A systematic review.
    Panchalingam S; Kasivelu G
    Brain Res; 2024 Sep; 1838():148990. PubMed ID: 38734122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA Expression and Interaction Patterns Are Perturbed in Amyotrophic Lateral Sclerosis.
    Aquilina-Reid C; Brennan S; Curry-Hyde A; Teunisse GM; The Nygc Als Consortium ; Janitz M
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
    Kwak S
    Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis.
    Karagianni K; Dafou D; Xanthopoulos K; Sklaviadis T; Kanata E
    Mol Med; 2024 Jul; 30(1):101. PubMed ID: 38997636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.
    Yamashita T; Kwak S
    Neurosci Res; 2019 Jul; 144():4-13. PubMed ID: 29944911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model.
    Akamatsu M; Yamashita T; Teramoto S; Huang Z; Lynch J; Toda T; Niu L; Kwak S
    Life Sci Alliance; 2022 Apr; 5(4):. PubMed ID: 35022247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases.
    Hosaka T; Yamashita T; Tamaoka A; Kwak S
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis.
    Yamashita T; Akamatsu M; Kwak S
    Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate receptors: RNA editing and death of motor neurons.
    Kawahara Y; Ito K; Sun H; Aizawa H; Kanazawa I; Kwak S
    Nature; 2004 Feb; 427(6977):801. PubMed ID: 14985749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FUS Alters circRNA Metabolism in Human Motor Neurons Carrying the ALS-Linked P525L Mutation.
    Colantoni A; Capauto D; Alfano V; D'Ambra E; D'Uva S; Tartaglia GG; Morlando M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNAs as Potential Blood Biomarkers in Amyotrophic Lateral Sclerosis.
    Dolinar A; Koritnik B; Glavač D; Ravnik-Glavač M
    Mol Neurobiol; 2019 Dec; 56(12):8052-8062. PubMed ID: 31175544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
    Hideyama T; Yamashita T; Nishimoto Y; Suzuki T; Kwak S
    J Pharmacol Sci; 2010; 113(1):9-13. PubMed ID: 20424386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPA receptor-mediated neuronal death in sporadic ALS.
    Kwak S; Hideyama T; Yamashita T; Aizawa H
    Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Death of motor neurons and molecular change of glutamate receptors in ALS].
    Shin K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):982-4. PubMed ID: 16447780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.